Bellerophon Therapeutics Inc (BLPH) Insider Trading
- $7,187,923.47
- $8,302,225.43
- Oct. 13, 2023
- Associates Iv L P Venrock
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 13, 2023 | Major Shareholder | 1,076,841 | $0.10 | Sell | $107,684.10 | |
| June 7, 2023 | Major Shareholder | 134,421 | $0.83 | Sell | $111,569.43 | |
| May 18, 2023 | Major Shareholder | 560,000 | $9.46 | Sell | $5,297,600.00 | |
| May 18, 2023 | VP | 9,455 | $10.00 | Sell | $94,550.00 | |
| March 18, 2021 | Major Shareholder | 400,000 | $5.48 | Sell | $2,192,000.00 | |
| Sept. 10, 2020 | Insider | 4,000 | $10.18 | Buy | $40,720.00 | |
| Nov. 25, 2019 | Director | 7,193 | $0.39 | Buy | $2,805.27 | |
| Nov. 21, 2019 | Director | 200 | $0.37 | Buy | $74.00 | |
| Oct. 28, 2019 | Major Shareholder | 333,010 | $0.44 | Sell | $146,524.40 | |
| Oct. 24, 2019 | Major Shareholder | 704,595 | $0.50 | Sell | $352,297.50 | |
| June 12, 2019 | Director | 50,000 | $0.64 | Buy | $32,000.00 | |
| May 21, 2019 | CEO | 5,000 | $0.60 | Buy | $3,000.00 | |
| May 21, 2019 | Director | 20,000 | $0.61 | Buy | $12,200.00 | |
| Jan. 25, 2019 | Director | 571,429 | $0.70 | Buy | $400,000.30 | |
| Sept. 17, 2018 | Major Shareholder | 210,000 | $1.20 | Buy | $252,000.00 | |
| Sept. 14, 2018 | Major Shareholder | 75,000 | $1.23 | Buy | $92,250.00 | |
| Sept. 12, 2018 | Major Shareholder | 475,000 | $1.18 | Buy | $560,500.00 | |
| Sept. 10, 2018 | Major Shareholder | 200,000 | $1.22 | Buy | $244,000.00 | |
| Sept. 7, 2018 | Major Shareholder | 160,000 | $0.86 | Buy | $137,600.00 | |
| Sept. 5, 2018 | Major Shareholder | 50,000 | $0.85 | Buy | $42,500.00 | |
| Aug. 16, 2018 | Major Shareholder | 529,370 | $0.65 | Buy | $344,090.50 | |
| Dec. 9, 2016 | Director | 20,000 | $0.56 | Buy | $11,200.00 | |
| May 17, 2016 | CEO | 5,000 | $1.37 | Buy | $6,850.00 | |
| Dec. 16, 2015 | CEO | 20,300 | $2.75 | Buy | $55,825.00 | |
| Aug. 19, 2015 | CEO | 5,000 | $5.48 | Buy | $27,400.00 | |
| May 20, 2015 | CEO | 5,560 | $8.69 | Buy | $48,316.40 | |
| Feb. 19, 2015 | Insider | 1,500 | $12.00 | Buy | $18,000.00 | |
| Feb. 19, 2015 | Major Shareholder | 358,916 | $12.00 | Buy | $4,306,992.00 | |
| Feb. 19, 2015 | CEO | 20,800 | $12.00 | Buy | $249,600.00 | |
| Feb. 19, 2015 | Director | 25,000 | $12.00 | Buy | $300,000.00 |
Insiders are both buying and selling Bellerophon Therapeutics Inc stock.
The insider traders at Bellerophon Therapeutics Inc are: Associates Iv L P Venrock, Jonathan M Peacock, Theodore T Wang, Life Science Opportu Puissance, Jens Luehring, Fabian Tenenbaum, Jonathan M. Peacock, Daniel Tasse, Linde North America, Inc., Manesh Naidu, Naseem Amin, New Mountain Investments Ii, L, Puissance Capital Management L, Bobae Kim, and Wassim Fares
The most active insider trader at Bellerophon Therapeutics Inc is Associates Iv L P Venrock with 9 trades.
Life Science Opportu Puissance has sold the most Bellerophon Therapeutics Inc stock with a total value of $5,520,738.86.
Linde North America, Inc. has bought the most Bellerophon Therapeutics Inc stock with a total value of $8,613,984.00.
The most recent insider trade for Bellerophon Therapeutics Inc was on Oct. 13, 2023.
The single biggest insider buy for Bellerophon Therapeutics Inc was from Linde North America, Inc. with a total value of $4,306,992.00 on Feb. 19, 2015.
The single biggest insider sell for Bellerophon Therapeutics Inc was from Life Science Opportu Puissance with a total value of $5,297,600.00 on May 18, 2023.